SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing intense scrutiny following a Q4 report that featured a double earnings beat but was overshadowed by a significant, disappointing guidance cut. While the community is actively debating whether the stock is undervalued at current levels or if the brand is suffering from weakened demand and increased competition, the broader sentiment remains cautious as investors weigh potential leadership changes and long-term growth prospects against immediate margin pressures.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors weigh a wave of regulatory progress, including recent DOE and NRC approvals, against the pressure of an upcoming earnings release. The community remains deeply polarized, with bulls focused on long-term data center partnerships and nuclear energy demand, while bears point to the company's pre-revenue status and significant insider selling as red flags.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is currently experiencing significant volatility as investors closely monitor for updates regarding a potential anchor tenant and the scaling of their data center infrastructure. The community is actively debating the company's long-term potential versus concerns about leadership transparency, with many traders focused on volume patterns and the impact of speculative rotations in the AI-energy sector.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is generating significant market buzz following its recent IPO as retail investors flock to the drone and autonomous defense software provider. The community is actively debating its high-growth potential and low-float volatility, with many traders drawing parallels to other explosive defense-tech runners while tracking its performance amid ongoing global geopolitical instability.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending as the community highlights recent clinical trial progress, including a significant reduction in breast cancer recurrence rates within the open-label arm of the FLAMINGO-01 trial. Investors are actively discussing the upcoming publication of abstract titles for the AACR annual meeting, with many viewing the involvement of the full Steering Committee as a strong signal of scientific credibility and potential institutional backing.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign is currently a focal point for investors debating the stock's future, as the company faces intensified competition from AI-driven tools while simultaneously leveraging strategic partnerships and share buybacks. Community sentiment remains polarized between those identifying a potential value-based rebound driven by institutional accumulation and those who fear the firm's business model is increasingly vulnerable to technological disruption.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is surging to all-time highs as traders pile into calls and sentiment remains extremely bullish ahead of an earnings report, bolstered by the recent completion of a major Taiwan facility acquisition and news that HBM4 supply is largely booked through 2026. The community is intensely focused on whether this rally has already priced in an earnings blowout or if the stock's role as an indispensable AI infrastructure provider will trigger further upside toward the 500-level.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is catching investor attention as it rides a massive wave of AI-driven memory and storage demand, with shares benefiting from robust sector momentum and a substantial new share buyback program. While some traders are expressing caution regarding potential volatility and valuation concerns, the community is actively debating whether the current rally represents a long-term breakout or a temporary peak ahead of further industry growth.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is facing intense volatility as market participants debate a new short-seller report alleging accounting irregularities, which has triggered heavy trading volume and prompted a rapid V-shaped recovery attempt. While bears are pushing concerns over loan valuations and debt, long-term investors are actively buying the dip, bolstered by recent significant insider purchases from the CEO that have fueled speculation of an imminent squeeze.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing a surge in investor interest and trading volume ahead of its upcoming earnings call, with the community actively speculating about a potential buyout and the company's ability to reach critical valuation targets. Investors are closely monitoring the stock's momentum, with ongoing discussions centered on Briumvi's market performance, upcoming sub-Q clinical data, and the potential for a performance-based bonus for management to act as a catalyst for a strategic move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anixa Biosciences (NASDAQ:ANIX) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered shares of Anixa Biosciences from a "hold" rating to a "sell" rating in a research report on Sunday...

Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress

Anixa Biosciences (NASDAQ:ANIX) held its 2026 Annual Meeting of Stockholders via live webcast, outlining the results of shareholder votes and providing an operational update focused on the company's...

Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast

Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast PR Newswire SAN JOSE, Calif., March...

Anixa Biosciences (NASDAQ:ANIX) Posts Earnings Results, Beats Expectations By $0.01 EPS

Anixa Biosciences (NASDAQ:ANIX - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01...

Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology

Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology Anixa Biosciences Receives Notice of Allowance...

Anixa Biosciences (NASDAQ:ANIX) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded Anixa Biosciences from a "sell" rating to a "hold" rating in a research note on Saturday...

Anixa Biosciences (ANIX) to Release Earnings on Tuesday

Anixa Biosciences (NASDAQ:ANIX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress Anixa Biosciences to Host 2026 Annual Meeting of...

Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Analysts

Shares of Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) have been assigned an average recommendation of "Hold" from the five brokerages that are covering the company, MarketBeat.com reports...

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat Anixa Biosciences Announces Dr. Jose Conejo-Garcia will...

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The Other segment refers to its legacy operations, including patent licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

ANIX
Anixa Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ANIX News

ANIXAnixa Biosciences Inc